Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF NAD-RELATED METABOLITE
Document Type and Number:
WIPO Patent Application WO/2018/030389
Kind Code:
A1
Abstract:
The present invention provides a food (particularly a supplement, a health supplement, a food for specified health uses, a food having a nutrient function, or a food having function claims) and a preparation for external application (particularly a medicine (a medicine for medical uses, an OTC), a quasi drug, a cosmetic, and a skin care product), each of which contains an NAD-related metabolite or a pharmaceutically acceptable salt or prodrug thereof. The present invention also provides a pharmaceutical composition for preventing or treating an ophthalmic disease selected from the group consisting of presbyopia, glaucoma, diabetic retinopathy, retinitis pigmentosa, age-related macular degeneration, chorioretinal atrophy associated with high myopia, corneal endothelial dystrophy , bullous keratopathy, cataract, retinal artery/vein occlusion, Fuchs's corneal dystrophy, bullous keratopathy, optic neuropathy and Leber's disease.

Inventors:
TSUBOTA KAZUO (JP)
INAGAKI EMI (JP)
OKANO HIDEYUKI (JP)
Application Number:
PCT/JP2017/028727
Publication Date:
February 15, 2018
Filing Date:
August 08, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV KEIO (JP)
International Classes:
A23L33/13; A61K8/04; A61K8/49; A61K8/60; A61K9/06; A61K9/08; A61K9/10; A61K9/14; A61K9/20; A61K9/48; A61K31/455; A61K31/706; A61K31/7084; A61P3/02; A61P17/00; A61P27/02; A61P27/04; A61P27/06; A61P27/12; A61Q19/00
Domestic Patent References:
WO2015069860A12015-05-14
Foreign References:
JP2008501343A2008-01-24
JP2006298876A2006-11-02
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF: